Soeda et al. also demonstrated a higher sensitivity of the salivary glands to increasing amounts of peptide compared to tumor tissue using [18F]PSMA-1007, potentially minimizing xerostomia during PSMA radioligand therapy (RLT)15. The gene discussed is FOLH1; the disease is neoplasm.